Fig. 1From: Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, UgandaCumulative incidence of switching to second-line ART by CD4 count at ART initiationBack to article page